PreprintAll rights reservedmedRxiv
VSV-EBOV vaccination induces cross-reactive T-cell responses against Bundibugyo virus in humans
- 1Institute for Infection Research and Vaccine Development (IIRVD), University Medical Centre Hamburg-Eppendorf, Hamburg, Germany
Related
- Cross-reactive antibody and functional T-cell responses to Bundibugyo virus induced by Zaire ebolavirus vaccination and infection
- Cross-Reactive Bundibugyo Antibody Responses after Receipt of Licensed Ebola Vaccines
- Evidence for cross-reactivity and protection against Bundibugyo virus disease after heterologous vaccination: a systematic review and meta-analysis
- Conserved nucleocapsid epitopes induce cross-reactive CD4⁺ T-cell responses with selective protection against human coronaviruses in mice.
- The mRNA-based RSV vaccine mRNA-1345 induces robust and durable CD4 ⁺ T cell responses against RSV in younger and older adults
BibTeX
@misc{mayer2026vsvebov,
title = {{VSV-EBOV vaccination induces cross-reactive T-cell responses against Bundibugyo virus in humans}},
author = {L. Mayer and R. Londt and E. Gruener and M. L. Ly and M. M. Addo and C. Geldmacher},
howpublished = {medRxiv},
year = {2026},
month = sep,
doi = {10.64898/2026.09.25.26363765},
url = {https://www.medrxiv.org/content/10.64898/2026.09.25.26363765v1},
}
RIS
TY - UNPB
TI - VSV-EBOV vaccination induces cross-reactive T-cell responses against Bundibugyo virus in humans
AU - L. Mayer
AU - R. Londt
AU - E. Gruener
AU - M. L. Ly
AU - M. M. Addo
AU - C. Geldmacher
PY - 2026
DA - 2026/09/25
PB - medRxiv
DO - 10.64898/2026.09.25.26363765
UR - https://www.medrxiv.org/content/10.64898/2026.09.25.26363765v1
ER -